文献速递血栓与止血

斑马鱼凝血因子VIII缺失可再平衡抗凝血酶缺乏但出血素质有限

Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis.
PubMed 文献 · Blood Adv · 2025-01-01

研究利用基因编辑在斑马鱼中构建f8与vwf无效等位基因,观察凝血因子VIII(FVIII)缺失及与抗凝血酶(AT3)双缺失时的止血表型。f8纯合突变幼鱼经激光诱导内皮损伤后仍形成正常血栓、无明显出血,但死亡率轻度升高;f8-/-;at3-/-幼鱼不再发生自发性纤维蛋白血栓并能对损伤产生血栓,而Vwf纯合缺失未能挽救at3缺乏的表型。

要点

  • f8纯合突变斑马鱼幼鱼经激光内皮损伤仍形成正常血栓,无明显出血征象,死亡率轻度升高。
  • f8-/-;at3-/-幼鱼不再出现自发性纤维蛋白血栓,且内皮损伤后能形成血栓。
  • Vwf纯合缺失未能挽救at3缺乏导致的弥散性血管内凝血表型。

核心结论

  • 斑马鱼中天然抗凝物的平衡改变可减轻FVIII缺乏,类似临床在研的止血药物,并提示斑马鱼FVIII可能不依赖Vwf循环。

研究设计与样本

  • 研究采用基因编辑在斑马鱼中构建f8与vwf无效等位基因,并以激光介导内皮损伤模型观察血栓形成。

主要发现

  • f8纯合突变幼鱼经激光介导内皮损伤后形成正常血栓,无明显出血征象,但死亡率轻度升高。
  • f8-/-;at3-/-幼鱼不再发生自发性纤维蛋白血栓,并能对内皮损伤产生血栓。
  • Vwf纯合缺失未能挽救at3缺乏的弥散性血管内凝血表型。

临床怎么用

  • 作者认为进一步探索斑马鱼这一独特平衡可能为血友病A与血管性血友病的治疗提供新见解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Deficiencies in coagulation factor VIII (FVIII, F8) result in the bleeding disorder hemophilia A. An emerging novel therapeutic strategy for bleeding disorders is to enhance hemostasis by limiting natural anticoagulants, such as antithrombin (AT3). To study pro/anticoagulant hemostatic balance in an in vivo model, we used genome editing to create null alleles for f8 and von Willebrand factor (vwf) in zebrafish, a model organism with a high degree of homology to the mammalian hemostatic system and unique attributes, including external development and optical transparency. f8 homozygous mutant larvae surprisingly formed normal thrombi when subjected to laser-mediated endothelial injury, had no overt signs of hemorrhage, although they did have a modest increase in mortality. We have previously shown that at3-/- larvae develop disseminated intravascular coagulation (DIC), with spontaneous thrombosis and fibrinogen consumption, resulting in a bleeding phenotype marked by secondary lack of induced thrombus formation upon endothelial injury. We found that with loss of FVIII (f8-/-;at3-/-), larvae no longer developed spontaneous fibrin thrombi and produced clots in response to endothelial injury. In contrast, homozygous loss of zebrafish Vwf failed to rescue the at3 DIC phenotype. These findings demonstrate an altered balance of natural anticoagulants that mitigates FVIII deficiency in zebrafish, similar to hemostatic drugs in the clinical development pipeline, and suggest that zebrafish FVIII might circulate independently of Vwf. Further exploration of this unique balance in zebrafish could provide novel insights into the treatment of hemophilia A and von Willebrand disease.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Raghunath A, Richter CE, Griffin MS, et al. Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis. Blood Adv. 2025. PMID: 40085950. doi:10.1182/bloodadvances.2024013143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。